Clinical Trial Update: Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating pharmacogenetics-guided dosing to determine the maintenance dose of warfarin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Mechanical Heart Valve
• Venous Thromboembolism

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Indications for Warfarin Therapy | Phase 3 | Status: UNKNOWN